METTL3 and colorectal carcinoma: Mechanistically, the expression of the methyltransferase METTL3 is increased in oxaliplatin-resistant CRC tissues, and METTL3-mediated N6-adenosine methylation significantly inhibits TRAF5-induced necroptosis both in vitro and in vivo [212].